Novo Nordisk to buy French developer of digital injection pen add-on
French biotech company Biocorp, a developer of digital add-on units for injection pens, could become part of Novo Nordisk in the future.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Nordisk moves digital unit, appoints new head
For subscribers
French Biocorp enters smart pen partnership with Merck
For subscribers